IP Library Granted Patent US 10,316,284
Granted Patent B2
US 10,316,284 · App. 15/126,236 · Granted Jun 11, 2019

Implantable biocompatible reactor

Inventors: Sarra El Ichi (La Tronche, FR); Donald K. Martin (La Tronche, FR); Philippe Cinquin (La Tronche, FR); Abdelkader Zebda (La Tronche, FR)
Assignee: Universite Grenoble Alpes
C12M29/04B29C41/003B29C65/4805G01N27/3271H01M4/8605H01M4/8663H01M4/8673H01M4/8896H01M4/9008H01M4/9083H01M8/16B29K2005/00B29K2995/0068B29L2031/34B29L2031/755H01M2250/30Y02B90/18Y02E60/527
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,316,284
App. No.
15/126,236
Granted
Jun 11, 2019
Kind
B2
Abstract

The invention concerns a bioreactor obtained by compressing a mixture of an enzyme, a conductor and chitosan. The conductor can consist of carbon nanotubes. This bioreactor can be produced according to the following steps: preparing a mixture of powders in which the proportion of enzyme powder relative to a carbon nanotube powder is of the order of 50/50 by weight; preparing a viscous solution of chitosan in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% by volume in water; adding the viscous chitosan to the mixture of powders in a proportion be weight of 3 to 5 of powder to 5 to 10 of chitosan; carrying out a first compression followed by light grinding; carrying out a second compression to produce a pellet; and drying at ambient temperature.

Claims (23)

1. A bioreactor obtained by a method comprising the steps of:

preparing a mixture of an enzyme powder and a carbon nanotube powder where the proportion of enzyme powder relative to carbon nanotube powder is of the order of 50/50 by weight;

preparing a viscous solution of chitosan in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% by volume in water;

adding the viscous chitosan to the mixture of enzyme powder and carbon nanotube powder in a proportion by weight of 3 to 5 of this mixture to 5 to 10 of chitosan;

carrying out a first compression followed by light grinding;

carrying out a second compression to produce a pellet; and

drying at ambient temperature.

2. The bioreactor of claim 1 , wherein the pressure applied during the first and the second compression is within a range from 2,000 to 6,000 kPa.

3. The bioreactor of claim 1 , wherein the solution comprises from 0.002 to 0.005% in mass per volume of genipin.

4. The bioreactor of claim 1 , wherein the solution comprises from 0.001 to 0.005% in mass per volume of caffeic acid.

5. The bioreactor of claim 1 , wherein a porous chitosan-based membrane is laid on an active surface of the bioreactor and bonded at the periphery thereof.

6. The bioreactor of claim 5 , wherein the porous chitosan-based membrane is obtained by a method comprising the steps of:

preparing a solution in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% in water;

stirring;

pouring on a smooth support; and

drying for a period from 2 to 4 days at ambient temperature.

7. The bioreactor of claim 5 , having a pellet-shaped bioelectrode, wherein a conductor is glued by means of conductive glue to the surface of the pellet-shaped bioelectrode opposite to the active surface.

8. The bioreactor of claim 5 , wherein the membrane comprises a plurality of pores having an average diameter in the range from 1 to 10 nanometers.

9. The bioreactor of claim 5 , wherein the membrane comprises a smooth surface facing the pellet-shaped electrode and a rough surface facing outwards.

10. The bioreactor of claim 7 , wherein the membrane comprises a plurality of pores having an average diameter in the range from 1 to 10 nanometers.

11. The bioreactor of claim 7 , wherein the membrane comprises a smooth surface facing the pellet-shaped electrode and a rough surface facing outwards.

12. The bioreactor of claim 2 , wherein the solution comprises from 0.002 to 0.005% in mass per volume of genipin.

13. The bioreactor of claim 2 , wherein the solution comprises from 0.001 to 0.005% in mass per volume of caffeic acid.

Assignments (3)
MERGER Recorded Jun 2, 2022
From: UNIVERSITÉ GRENOBLE ALPES
To: UNIVERSITE GRENOBLE ALPES
Reel/Frame 060085/0145 →
MERGER Recorded Feb 3, 2022
From: UNIVERSITE JOSEPH FOURIER
To: UNIVERSITE GRENOBLE ALPES
Reel/Frame 058872/0096 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2016
From: EL ICHI, SARRA; MARTIN, DONALD K; CINQUIN, PHILIPPE; ZEBDA, ABDELKADER
To: UNIVERSITE GRENOBLE ALPES
Reel/Frame 040516/0617 →
Priority Claims (1)
FR 14 52534 · Mar 25, 2014 · national
Continuity (1)
Related Publication 20170081626A1 · Mar 23, 2017
Cited By (1)
US 12,456,737